Quoin Pharmaceuticals Ltd. (QNRX) stock
QNRXNasdaqPharmaceutical Preparations
$3.56+0.20 (+5.95%)
Close on Nov 18, 2026Market cap $7.15MP/E –Yield –
Quoin Pharmaceuticals operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2020 it was -$4.35M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -$4.35M | – |
| FY2019 | Dec 31, 2019 | -$6.46M | – |
| FY2017 | Dec 31, 2017 | -$7.05M | – |
See a number that looks wrong?